Mereo BioPharma Group plc (MREO) › Net IncomeMereo BioPharma Group plc (MREO) — Net IncomeAnnual figures by period end, from SEC filings.2022-12-31: -$42.22M2023-12-31: -$29.47M2024-12-31: -$43.25M2025-12-31: -$41.88M-$41.88M2022-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$41.88M—2026-03-19From 2025-01-012024-12-31-$43.25M—2026-03-19From 2024-01-012023-12-31-$29.47M—2025-03-26From 2023-01-012022-12-31-$42.22M—2024-03-27From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)